|
Post by gamblerjag on Oct 2, 2017 9:42:53 GMT -5
I almost wish they can say " The fastest rapid acting insulin that just happens to be inhaled. To say the fastest inhaled inslulin almost makes it sound that it's only the "fastest inhaled insulin ".. no that is not a soft bash.. lol
|
|
|
Post by itellthefuture777 on Oct 2, 2017 9:47:19 GMT -5
2017-2018 Nurse book says Afrezza onset "immediate" I'd say that's pretty dang fast..
|
|
|
Post by joeypotsandpans on Oct 2, 2017 9:49:40 GMT -5
I'm baffled that this is dropping like a rock today? Apparently the FDA decision was seen as bad news or a non-newsworthy item? SMH People used to say to me, all priced in. grrrr. The day isn't over. It would be nice to see buyers come in. The stock is the definition of over head resistance.
Peppy if they don't get it by now then I'm not sure why they're still on board so no need to get frustrated....for all those that listened to the call if you're disappointed then you can't be helped and shouldn't be invested in this stock at this point. Al himself couldn't of picked a better person to pass the baton to and lead his company and further his legacy IMO. This young PharmD is smart, sharp, and exudes confidence. Mike said this removes handcuffs or to paraphrase him "no more one hand tied behind their backs" referring to the reps as to what they can say regarding superiority by way of reduction of potential hypo's compared to current Raa's. As to the title of this thread, for someone short today the cost to borrow is still right at 90% with no shares available. So if there were any real selling that would not be the case and you can also see that there has been virtually little to no closing out of call positions. Those longs that know what they hold will most likely stay focused and ignore the smoke and mirror noise that continues with the same "alien" characters that continue to plague the board and SA and attempt to free up shares that couldn't be bought at .13/sh. and I am with you more than you know regarding hoping he was referring to UHC as the large payor on deck.
|
|
|
Post by therealisaching on Oct 2, 2017 9:58:02 GMT -5
People used to say to me, all priced in. grrrr. The day isn't over. It would be nice to see buyers come in. The stock is the definition of over head resistance.
Peppy if they don't get it by now then I'm not sure why they're still on board so no need to get frustrated....for all those that listened to the call if you're disappointed then you can't be helped and shouldn't be invested in this stock at this point. Al himself couldn't of picked a better person to pass the baton to and lead his company and further his legacy IMO. This young PharmD is smart, sharp, and exudes confidence. Mike said this removes handcuffs or to paraphrase him "no more one hand tied behind their backs" referring to the reps as to what they can say regarding superiority by way of reduction of potential hypo's compared to current Raa's. As to the title of this thread, for someone short today the cost to borrow is still right at 90% with no shares available. So if there were any real selling that would not be the case and you can also see that there has been virtually little to no closing out of call positions. Those longs that know what they hold will most likely stay focused and ignore the smoke and mirror noise that continues with the same "alien" characters that continue to plague the board and SA and attempt to free up shares that couldn't be bought at .13/sh. and I am with you more than you know regarding hoping he was referring to UHC as the large payor on deck. Joey - agree with your sentiments. I think Mike referred to a PBM coming on board. I would think this is CVS/Caremark. They have good coverage with Express Scripts & seemingly zero with CVS as a PBM.
|
|
|
Post by celo on Oct 2, 2017 10:10:55 GMT -5
Peppy if they don't get it by now then I'm not sure why they're still on board so no need to get frustrated....for all those that listened to the call if you're disappointed then you can't be helped and shouldn't be invested in this stock at this point. Al himself couldn't of picked a better person to pass the baton to and lead his company and further his legacy IMO. This young PharmD is smart, sharp, and exudes confidence. Mike said this removes handcuffs or to paraphrase him "no more one hand tied behind their backs" referring to the reps as to what they can say regarding superiority by way of reduction of potential hypo's compared to current Raa's. As to the title of this thread, for someone short today the cost to borrow is still right at 90% with no shares available. So if there were any real selling that would not be the case and you can also see that there has been virtually little to no closing out of call positions. Those longs that know what they hold will most likely stay focused and ignore the smoke and mirror noise that continues with the same "alien" characters that continue to plague the board and SA and attempt to free up shares that couldn't be bought at .13/sh. and I am with you more than you know regarding hoping he was referring to UHC as the large payor on deck. Joey - agree with your sentiments. I think Mike referred to a PBM coming on board. I would think this is CVS/Caremark. They have good coverage with Express Scripts & seemingly zero with CVS as a PBM. The PBM (pharmacy benefit manager) is coming on board in january? January because that is the beginning of the new year and is when contracts get rewritten? I don't know enough about a PBM to understand it's importance. It sounds like PBMs handle drug plans and cost of medications. But why january? Why not now?
|
|
|
Post by dreamboatcruise on Oct 2, 2017 10:20:41 GMT -5
Joey - agree with your sentiments. I think Mike referred to a PBM coming on board. I would think this is CVS/Caremark. They have good coverage with Express Scripts & seemingly zero with CVS as a PBM. That indeed would be good news. With Medicare coverage also increasing in 2018, we should finally be getting up to coverage levels comparable to other insulins. That will be an important part of the story for reps to present to doctors.
|
|
|
Post by peppy on Oct 2, 2017 10:23:53 GMT -5
Joey - agree with your sentiments. I think Mike referred to a PBM coming on board. I would think this is CVS/Caremark. They have good coverage with Express Scripts & seemingly zero with CVS as a PBM. The PBM (pharmacy benefit manager) is coming on board in january? January because that is the beginning of the new year and is when contracts get rewritten? I don't know enough about a PBM to understand it's importance. It sounds like PBMs handle drug plans and cost of medications. But why january? Why not now? celo, I have learned a bit more about the system on this board. it seems pharmacy purchasing managers make deals with pharmaceutical companies. one such deal, The PBM get rebates from the manufacturers when certain script numbers are hit. so if sanofi has the contract or novo has the contract, the pharmacy purchasing managers make more money for their shareholders with the rebate the manufacturer pays. it is all about money. this is done with justification my them with the fda label.
perhaps someone else can describe this better.
|
|
|
Post by nylefty on Oct 2, 2017 10:25:30 GMT -5
I'm baffled that this is dropping like a rock today? Apparently the FDA decision was seen as bad news or a non-newsworthy item? SMH "Dropping like a rock" is a pet peeve of this old editor. Rocks drop 100 percent (and MNKD is actually UP today).
|
|
|
Post by babaoriley on Oct 2, 2017 10:29:42 GMT -5
Floating like a balloon is more like it!! Nice rally here, guys!
|
|
|
Post by saxcmann on Oct 2, 2017 10:30:18 GMT -5
peppy, you're right! the day isn't over. I still feel dilution is near but for now pps is green!
|
|
|
Post by novafett on Oct 2, 2017 10:44:05 GMT -5
I'm baffled that this is dropping like a rock today? Apparently the FDA decision was seen as bad news or a non-newsworthy item? SMH "Dropping like a rock" is a pet peeve of this old editor. Rocks drop 100 percent (and MNKD is actually UP today). All about timing Lefty.. was dropping when i typed that up. Rock.. semantics i guess.
|
|
|
Post by me on Oct 2, 2017 10:46:50 GMT -5
|
|
|
Post by thoth on Oct 2, 2017 12:15:49 GMT -5
What me said. The two charts have similar shapes, but are nowhere close to being the same. It's like saying a golf ball and a basketball are the same size because they both happen to be spheres. In particular, look at the y-axis and the units used on one chart vs. the next.
|
|
|
Post by digger on Oct 2, 2017 14:46:34 GMT -5
What me said. The two charts have similar shapes, but are nowhere close to being the same. It's like saying a golf ball and a basketball are the same size because they both happen to be spheres. In particular, look at the y-axis and the units used on one chart vs. the next. When I read figure 1 in that ncbi link, I see fiasp starting at 5 minutes and peaking around 30-40 minutes. What do you see?
|
|
|
Post by golfeveryday on Oct 2, 2017 16:42:42 GMT -5
today is over. long term it's not over. we freed up 22 million shares so we can dilute. today is over! Or sell them to a partner. Once the warrant conversion to common shares closes tomorrow, I think we begin to hear more.
|
|